14158 Results (Page 448 of 567)
All Market Research Reports
Russia Artificial Intelligence (AI) in Diagnostics Market Analysis
Russia's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $16.3 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by encouraging government efforts & a strong focus on technical innovation. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & TeleMD.
Singapore Artificial Intelligence (AI) in Diagnostics Market Analysis
The Singapore Artificial Intelligence (AI) in the diagnostics market is projected to grow from $1.2 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by increasing demand for healthcare services such as AI diagnostics to improve patient outcomes and the government's support for AI research and development. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Claritas HealthTech.
Ireland Artificial Intelligence (AI) in Diagnostics Market Analysis
Ireland's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by via rise in the financing, collaborations, supportive regulatory frameworks, and the availability of large amounts of medical data. The market is segmented by component & by diagnosis. Some of the major players include GE Healthcare, IBM Watson Health & Deciphex.
Venezuela Artificial Intelligence (AI) in Diagnostics Market Analysis
The Venezuela Artificial Intelligence (AI) in the diagnostics market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the rising rate of incidence of chronic illnesses and increasing demand for fast and effective diagnostic technologies. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Philips Healthcare.
US Medical Devices Market Analysis
The US medical devices market is projected to grow from $207 Bn in 2022 to $275 Bn by 2030, registering a CAGR of 3.60% during the forecast period of 2022-30. As the US population continues to age, the demand for medical devices is expected to increase. Older adults are more likely to have chronic health conditions that require monitoring and treatment, and medical devices can play a key role in managing these conditions. Some of the key players in the US medical device market include companies like Medtronic, Johnson & Johnson, GE Healthcare, and Abbott Laboratories, among others.
US Oncology Therapeutics Market Analysis
The US oncology therapeutics market is projected to grow from $83 Bn in 2022 to $172 Bn by 2030, registering a CAGR of 9.6% during the forecast period of 2022-30. The development of new and innovative cancer treatments, such as immunotherapies and targeted therapies, is driving the growth of the oncology therapeutics market. This market is highly competitive, with many large pharmaceutical companies and biotech companies competing for market share. Some of the major players in the market include Roche, Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, AstraZeneca, and Johnson & Johnson
US Lung Cancer Therapeutics Market Analysis
The US lung cancer therapeutics market is projected to grow from $4 Bn in 2022 to $6.5 Bn by 2030, registering a CAGR of 6.3% during the forecast period of 2022–30. According to the American Cancer Society, lung cancer is the leading cause of cancer deaths in the US for both men and women. In 2022, it is estimated that there will be about 235,760 new cases of lung cancer and 131,880 deaths from the disease in the US. Some of the key players in the US lung cancer therapeutics market include AstraZeneca, Pfizer, Roche, Merck, and Bristol-Myers Squibb, among others.
Brazil Rheumatology Drugs Market Analysis
Brazil's rheumatology drugs market is projected to grow from $1.526 Bn in 2022 to $2.057 Bn by 2030, registering a CAGR of 3.80% during the forecast period of 2022-2030. The prevalence of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis, and lupus, is high in Brazil, which drives the demand for rheumatology drugs. According to a study by the Brazilian Society of Rheumatology, around 30 million Brazilians suffer from some type of rheumatic disease. Aché is one of the largest pharmaceutical companies in Brazil, with a focus on research and development of innovative drugs. The company has a strong presence in the rheumatology drugs market, with products such as Artrinovo and Artril.
Germany Neurology Devices Market Analysis
Germany's neurology devices market size is at around $461.89 Mn in 2022 and is projected to reach $736.19 Mn in 2030, exhibiting a CAGR of 6% during the forecast period. The medical technology leader in manufacturing and engineering in Germany is home to several major market players in the neurological devices industry, including Medtronic, Boston Scientific, and St. Jude Medical, which are driving growth in the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
France Neurology Devices Market Analysis
France's neurology device market size is at around $347.05 Mn in 2022 and is projected to reach $587.44 Mn in 2030, exhibiting a CAGR of 6.8% during the forecast period. France has a high burden of neurology illnesses, and businesses such as Cerveau Technologies, In Vivo Neurotech, and NeuroMed Technologie dominate the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
Germany Acne Therapeutics Market Analysis
Germany acne therapeutics market is projected to grow from $367 Mn in 2022 to $538 Mn in 2030 with a CAGR of 4.9% for the forecast year 2022-2030. The market is anticipated to grow as most of the German population is becoming aware of acne and its treatment options. The Germany acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Pharall, Oranis, and Teva Pharmaceuticals are some of the key competitors in the market.
Egypt Acne Therapeutics Market Analysis
Egypt's acne therapeutics market is projected to grow from $28 Mn in 2022 to $53 Mn in 2030 with a CAGR of 8.2% for the year 2022-2030. Major market drivers include the growing prevalence of acne and the demand for novel therapeutics such as hormonal therapy for its treatment in Egypt. The Egypt acne therapeutics market is segmented by treatment, route of administration, age group, and by distribution channel. Copad Pharma, Delta Pharma, and Proactiv Company Sàrl are the key players in the market.
Brazil Acne Therapeutics Market Analysis
Brazil's acne therapeutics market is expected to witness growth from $251 Mn in 2022 to $454 Mn in 2030 with a CAGR of 7.7% for the year 2022-2030. The rising prevalence of acne and the demand for innovative treatments for its treatment in Brazil are the major drivers for the growth of the market. The Brazil acne therapeutics market is segmented by treatment, route of administration, age group, and by distribution channel. Some of the key players in the market include Mantecorp Farmasa, EMS Pharma, and Teva Pharmaceuticals.
Kenya Neurology Devices Market Analysis
The Kenya Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. In Kenya, neurological disorders are becoming more common as a result of factors like changing lifestyles, an older population, and increasing awareness. This is anticipated to increase the demand for neurology devices in Kenya. The market is segmented by product type and by the end user. Some key players in this market include Techno Brain Group, Biodeal Laboratories, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories.
Africa Neurology Devices Market Analysis
The Africa Neurology Device Market is expected to witness growth from $189 Mn in 2022 to $386 Mn in 2030 with a CAGR of 9.30% for the forecasted year 2022-2030. As the population ages, lifestyle and dietary trends shift, and the burden of non-communicable diseases rises, neurological disorders are becoming more prevalent in Africa, and this trend is predicted to continue in the years to come. In order to diagnose and treat these disorders, there is a higher need for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Stryker, Abbott laboratories and Philips Healthcare.
Turkey Patient Engagement Solutions Market Analysis
The Turkey patient engagement solutions market is projected to grow from $136.08 Mn in 2022 to $354.15 Mn by 2030, registering a CAGR of 12.7% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, the ageing population, technology adoption and government adoption. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Tiga Information Technologies, Siemens Healthineers, Oracle, IBM and Medtronic.
Tanzania Patient Engagement Solutions Market Analysis
The Tanzania patient engagement solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be rising healthcare costs, the growing prevalence of chronic diseases and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include AfyaPro, Siemens Healthineers, IBM and GE Healthcare.
Italy Acne Therapeutics Market Analysis
The Italy acne therapeutics market is projected to grow from $241 Mn in 2022 to $390 Mn in 2030 with a CAGR of 6.2% for the year 2022-2030. The rise in disposable incomes in Italy and growing skincare concerns are the major factors driving the expansion of the market. The Italy acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Farmabios SpA, AmypoPharma, and Allergan are some of the key players in the market.
Spain Acne Therapeutics Market Analysis
The Spain acne therapeutics market is expected to witness growth from $194 Mn in 2022 to $302 Mn in 2030 with a CAGR of 5.7% for the year 2022-2030. As more and more population becomes aware of the available acne therapies, the market for acne therapeutics is anticipated to expand. The Spain acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. TecnyFarma, Farmasierra, and GlaxoSmithKline are some of the key competitors in the market.
Sweden Patient Engagement Solutions Market Analysis
The Sweden patient engagement solutions market is projected to grow from $61.24 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be a focus on preventive care, the ageing population, digitalization of healthcare and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Pilloxa, Wolters Kluwer, Oracle, IBM, and Siemens Healthineers.
UK Acne Therapeutics Market Analysis
As Acne vulgaris continues to affect almost 34% of adults in the UK, the UK acne therapeutics market is expected to grow from $261 Mn in 2022 to $377 Mn in 2030 with a CAGR of 4.7% for the year 2022-2030. Revolutionary acne therapeutics options and acne awareness campaigns in the UK are responsible for the growth of the UK acne therapeutics market. The market is segmented by treatment, route of administration, age group, and by distribution channel. Chugai, Chatfield, and Takeda are some of the key competitors in the UK acne therapeutics market.
Hong Kong Patient Engagement Solutions Market Analysis
The Hong Kong patient engagement solutions market is projected to grow from $27.23 Mn in 2022 to $73.49 Mn by 2030, registering a CAGR of 13.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, digitalization of healthcare, advancements in technology and regulatory support from the government. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include ClinicOne, Wolters Kluwer, Medtronic, IBM and Oracle.
Europe Patient Engagement Solutions Market Analysis
The Europe patient engagement solutions market is projected to grow from $3.23 Bn in 2022 to $7.42 Bn by 2030, registering a CAGR of 10.94% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, increasing prevalence of chronic diseases, rising telemedicine remote monitoring services and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Medesk, Cambio Healthcare System, Orion Health, Mckesson, Oracle and Siemens Healthineers.
Turkey Artificial Intelligence (AI) in Diagnostics Market Analysis
Turkey's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $8 Mn in 2022 to $90.91 Mn by 2030, registering a CAGR of 35.5% during the forecast period of 2022-2030. The market will be driven by initiatives and collaborations promoting the development of AI-powered solutions and the rising incidence of chronic conditions. The market is segmented by component & by diagnosis. Some significant players include IBM Watson Health, Siemens Healthineers & Hayriya.
Brazil Cancer Pain Management Market Analysis
The Brazil Cancer Pain Management market is projected to grow from $163 Mn in 2022 to $265.74 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased incidences of cancer, an ageing population, the growing pharmaceutical industry and supportive government policies. The market is segmented by drug type and by disease. Some of the major players include Grunenthal Pharma, Hisamitsu Pharmaceutical, Mundipharma, Pfizer, Teva Pharmaceuticals and Abbott.
